Relay Therapeutics Congress Trades
NASDAQ: RLAYHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0
- Sales
- 0
- Politicians trading
- 0
- Latest trade
- Jul 12, 2023
Relay Therapeutics Congress trading summary
Members of Congress have disclosed 4 transactions in Relay Therapeutics (RLAY) stock, reported by 2 politicians. No RLAY trades were reported with a transaction date in the past 12 months. The most active traders are Eric S. Lander (3), Rep. Daniel S. Goldman (1).
The latest reported trade is a sale by Daniel S. Goldman dated Jul 12, 2023 and disclosed on Aug 13, 2023. The most common reported amount is $50,001 – $100,000; disclosures list value ranges, not exact amounts.
Summary generated from market data by MetaCap's automated system. Methodology
Politicians trading RLAY
RLAY trades by members of Congress
| Politician | Type | Amount | Traded | Filing |
|---|---|---|---|---|
 Daniel S. GoldmanD-NYHouse | Sell | $1,001 – $15,000 | Jul 12, 2023 | Filing for Daniel S. Goldman RLAY trade |
| Eric S. LanderExecutive | Sell | $50,001 – $100,000 | Jun 11, 2021 | Filing for Eric S. Lander RLAY trade |
| Eric S. LanderExecutive | Sell | $50,001 – $100,000 | Jun 11, 2021 | Filing for Eric S. Lander RLAY trade |
| Eric S. LanderExecutive | Sell | $100,001 – $250,000 | Jun 10, 2021 | Filing for Eric S. Lander RLAY trade |
Source: House Clerk and Senate EFD public disclosures. Trades are reported as dollar ranges and may be disclosed up to 45 days after the transaction.
Related
Source: House Clerk and Senate EFD public disclosures. Trades are reported as dollar ranges and may be disclosed up to 45 days after the transaction. Disclosures are shown as filed and are not a recommendation to buy or sell RLAY. How Congress trading data works